People delay seeking help for knee pain, assuming it's an unavoidable part of ageing. But Arthrosamid® offers patients a new ...

Biotechnology developers of sustained acoustic medicine report latest research documenting the effectiveness of the sam® ...

But Arthrosamid® offers patients a new pathway. Unlike traditional treatments, it's proven to offer respite from knee osteoarthritis with a single treatment, and without the need for surgery.( ...

A new study shows that a minimally invasive treatment for osteoarthritis (OA) in the knees may have a lasting benefit of at ...

Genicular arterial embolisation is a minimally invasive procedure that scientists hope will be able to help give some hope to ...

Most people with knee osteoarthritis can control their pain and improve their mobility without surgery, according to updated treatment guidelines from the Australian Commission on Safety and ...

Sun Pharma and Moebius Medical have received FDA fast track designation (FTD) for MM-II for osteoarthritis knee pain.

Late-stage drug development company Paradigm Biopharmaceuticals has a clear pathway from the FDA for progression of its Phase ...

RION, at the forefront of exosome innovation and therapeutic application, has officially commenced a Phase 1b study aimed at assessing the efficacy and safety of Purified Exosome Product™ (PEP™), its ...

MM-II is a proprietary suspension of large empty liposomes composed of dipalmitoylphosphatidylcholine and dimyristoylphosphatidylcholine.

An Israeli-Indian treatment for knee pain caused by osteoarthritis has received Fast Track designation by the US Food and ...